Rankings
▼
Calendar
ACRS Q3 2021 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$407M
Q3 2021 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$2M
+14.5% YoY
Gross Profit
$560,000
33.8% margin
Operating Income
-$20M
-1223.3% margin
Net Income
-$21M
-1274.6% margin
EPS (Diluted)
$-0.35
QoQ Revenue Growth
-9.0%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$263M
Total Liabilities
$47M
Stockholders' Equity
$217M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$1M
+14.5%
Gross Profit
$560,000
$260,000
+115.4%
Operating Income
-$20M
-$10M
-93.9%
Net Income
-$21M
-$11M
-98.4%
Revenue Segments
Laboratory Research Revenue
$1M
85%
Other Revenue
$244,000
15%
← FY 2021
All Quarters
Q4 2021 →